Contact us:
973-983-7429
support@4hcm.org

66 Ford Road - Suite 213B
Denville, NJ 07834
Stacey Titus • May 1, 2023
The University of Colorado Hospital – Aurora, CO

The University of Colorado is one of our newest HCMA Recognized Centers of Excellence. The UCHealth Team is honored to be recognized and work in partnership with the HCMA to genuinely provide the highest standard of care for patients with Hypertrophic Cardiomyopathy. The mission of the University of Colorado’s HCM Program is to improve the lives of patients with HCM by providing first-class medical care to patients and their families, by educating others and increasing the awareness of HCM, and by participating in innovative research to advance the field. The UC Health Team provides multidisciplinary care across the spectrum of the disease, with all adult specialists in a single location and pediatric specialists on an adjacent campus. The program’s values are patients first, integrity, and excellence.

The University of Colorado team consists of the following members:

David Raymer MD and Edward Gill MD as Co-directors

Electrophysiology: Alexis Tumolo MD

Pediatrics/Pediatric Electrophysiology: Stephanie Nakano MD

CT Surgery: Joseph Cleveland, MD

Genetics: Matthew Taylor MD/ Louis Mestroni MD

Heart Failure/Transplant: David Raymer MD

Imaging (MRI) Danie Groves MD

Imaging (advanced Echo) Edward Gill MD

Nursing Support:  Kristy Gama NP/Cassy Wilkins RN

Co-Director Edward Gill says, “With regard to scientific advancements, we anticipate participating in a number of clinical trials regarding HCM drugs in patients.

The breakthrough myosin inhibitor, Mavacamten, was developed at the University of Colorado at the Cardiovascular Institute at CU Boulder under Leslie Leinwand, Ph.D. Also, Dr. Mestroni has just recently learned of funding of her NIH RO1 grant that deals specifically with cardiac genetics.”

Please join HCMA as we feature The University of Colorado HCM team for our next virtual stop of the Bighearted Warriors Unite tour on May 23 at 8:30 PM EST. Highlights are as follows:  Introductions to the UCHealth team, Comprehensive HCM Center Care, HCM Echocardiography: A Primer for Patients, Kids are Not Little Adults: Unique Issues Affecting Children with HCM, & A Look into the Future: Artificial Intelligence & Gene Therapy for HCM. Register here for this free event:  https://4hcm.org/inspire_events/bighearted-warriors-unite-featuring-university-of-colorado-hospital/

Please visit for more information about The University of Colorado Hospital – HCM program in Aurora, CO, please visit:  https://4hcm.org/university-of-colorado-hospital/

Stacey Titus, Center of Excellence Coordinator

For more information on all HCMA Recognized Centers of Excellence, please visit  https://4hcm.org/center-of-excellence/.

HCMA Blog

March 24, 2025
Who should have genetic testing, and when?
A photo-realistic image of  heart, lit from behind, on a black background.
March 11, 2025
Health educator Sabrina Cuddy discusses common arrhythmias in HCM, like atrial flutter/fibrillation, ventricular tachycardia/fibrillation, left or right bundle branch block, PVC, PAC, and others. Some arrhythmias are harmless, while others are serious and need treatment.
Chart representing mavacamten trial results with total patients, and results in blue bar format.
By Gordon Fox March 10, 2025
Camzyos provided significant reduction of obstruction. Initially all patients were obstructed (that is, they had gradients of at least 30mmHg after valsalva maneuvers). After 3 months on Camzyos, about 57% were no longer obstructed. After 6 months, about 70% had no obstruction.
More Posts
Share by: